Barcelona (Spain) / The professor of pharmacoepidemiology at the University of Oxford, the Spanish Daniel Prieto-Alhambra, revealed on Wednesday that the Jenner Institute is producing the vaccine designed and developed by scientists from this British university to be able to distribute in December, once tested. The clinical trial of this vaccine is in phase 3.
“The laboratory has taken the risk of starting to produce the vaccine now so that, if it works, they can have it on the market immediately. The laboratory is already assuming that it will work. Phase 1 and 2 seem to be working,” said the professor.
According to Prieto-Alhambra in a radio interview, the Jenner Institute expects to have the final results of the clinical trial in late October or early November to demonstrate the efficacy of the vaccine.
“The Jenner Institute is working on one of the most advanced vaccines, it is already in phase 3, they have recruited hundreds of patients and they hope to have results by October or November. It would be the first to be marketed,” said the Spanish scientist.
Prieto-Alhambra acknowledged that “we still do not have the efficacy results. We do not know to what extent it protects” and specified that a “very large study of up to 10,000 people has to be carried out to be able to test it.” One of the countries where The study is being carried out in Brazil, where there are currently more cases of coronavirus.
The Jenner Institute, founded in 2005, is part of the Nuffield Department of Medicine at the University of Oxford and aims to develop vaccines for diseases of great importance to global public health such as malaria, tuberculosis or HIV. (June 17, 2020, EFE / PracticaEspañol)
Apuntes de gramática: (Español) 60 ejemplos con estar + gerundio: no participio, (Español) estar + gerundio